Geode Capital Management
LCTX icon

Geode Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Geode Capital Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$2.21M Sell
2,431,619
-2,053,967
-46% -$1.86M ﹤0.01% 3110
2025
Q1 		$2.03M Buy
4,485,586
+795,100
+22% +$359K ﹤0.01% 3026
2024
Q4 		$1.85M Buy
3,690,486
+11,206
+0.3% +$5.63K ﹤0.01% 3158
2024
Q3 		$3.33M Buy
3,679,280
+83,274
+2% +$75.4K ﹤0.01% 2950
2024
Q2 		$3.59M Buy
3,596,006
+342,950
+11% +$342K ﹤0.01% 2902
2024
Q1 		$4.82M Buy
3,253,056
+317,245
+11% +$470K ﹤0.01% 2726
2023
Q4 		$3.2M Buy
2,935,811
+168,874
+6% +$184K ﹤0.01% 2917
2023
Q3 		$3.27M Buy
2,766,937
+346,129
+14% +$408K ﹤0.01% 2860
2023
Q2 		$3.41M Buy
2,420,808
+1,138,808
+89% +$1.61M ﹤0.01% 2899
2023
Q1 		$1.92M Buy
1,282,000
+17,591
+1% +$26.4K ﹤0.01% 3046
2022
Q4 		$1.48M Buy
1,264,409
+13,253
+1% +$15.5K ﹤0.01% 3183
2022
Q3 		$1.41M Buy
1,251,156
+1,784
+0.1% +$2.02K ﹤0.01% 3219
2022
Q2 		$1.97M Sell
1,249,372
-1,026,601
-45% -$1.62M ﹤0.01% 3114
2022
Q1 		$3.5M Sell
2,275,973
-54,178
-2% -$83.4K ﹤0.01% 2982
2021
Q4 		$5.71M Sell
2,330,151
-11,363
-0.5% -$27.8K ﹤0.01% 2827
2021
Q3 		$5.9M Buy
2,341,514
+2,930
+0.1% +$7.38K ﹤0.01% 2811
2021
Q2 		$6.66M Buy
2,338,584
+1,072,633
+85% +$3.06M ﹤0.01% 2738
2021
Q1 		$2.97M Buy
1,265,951
+200,662
+19% +$471K ﹤0.01% 3059
2020
Q4 		$1.87M Buy
1,065,289
+43,745
+4% +$77K ﹤0.01% 3121
2020
Q3 		$956K Hold
1,021,544
– – ﹤0.01% 3229
2020
Q2 		$888K Sell
1,021,544
-655,975
-39% -$570K ﹤0.01% 3178
2020
Q1 		$1.39M Buy
1,677,519
+108,792
+7% +$90.1K ﹤0.01% 2869
2019
Q4 		$1.4M Buy
1,568,727
+27,939
+2% +$24.9K ﹤0.01% 3151
2019
Q3 		$1.51M Sell
1,540,788
-4,381
-0.3% -$4.29K ﹤0.01% 3074
2019
Q2 		$1.7M Buy
1,545,169
+92,863
+6% +$102K ﹤0.01% 3045
2019
Q1 		$1.9M Buy
1,452,306
+224,766
+18% +$294K ﹤0.01% 2884
2018
Q4 		$1.12M Sell
1,227,540
-132,928
-10% -$121K ﹤0.01% 3066
2018
Q3 		$2.8M Buy
1,360,468
+32,962
+2% +$67.8K ﹤0.01% 2702
2018
Q2 		$2.39M Buy
1,327,506
+61,477
+5% +$111K ﹤0.01% 2753
2018
Q1 		$2.98M Buy
1,266,029
+6,613
+0.5% +$15.6K ﹤0.01% 2540
2017
Q4 		$2.37M Buy
1,259,416
+39,047
+3% +$73.4K ﹤0.01% 2652
2017
Q3 		$3.03M Buy
1,220,369
+12,378
+1% +$30.8K ﹤0.01% 2499
2017
Q2 		$3.33M Buy
1,207,991
+15,410
+1% +$42.5K ﹤0.01% 2428
2017
Q1 		$3.6M Buy
1,192,581
+733,072
+160% +$2.21M ﹤0.01% 2307
2016
Q4 		$1.45M Buy
459,509
+19,013
+4% +$60K ﹤0.01% 2810
2016
Q3 		$1.5M Buy
440,496
+17,299
+4% +$59K ﹤0.01% 2720
2016
Q2 		$966K Buy
423,197
+14,093
+3% +$32.2K ﹤0.01% 2917
2016
Q1 		$1.03K Sell
409,104
-30,522
-7% -$77 ﹤0.01% 2867
2015
Q4 		$1.45M Buy
439,626
+30,058
+7% +$99.4K ﹤0.01% 2678
2015
Q3 		$991K Buy
409,568
+51,704
+14% +$125K ﹤0.01% 2874
2015
Q2 		$1.05M Buy
357,864
+2,404
+0.7% +$7.04K ﹤0.01% 2870
2015
Q1 		$1.43M Buy
355,460
+18,742
+6% +$75.1K ﹤0.01% 2660
2014
Q4 		$1.01M Buy
336,718
+5,748
+2% +$17.3K ﹤0.01% 2838
2014
Q3 		$838K Buy
330,970
+83,524
+34% +$211K ﹤0.01% 2884
2014
Q2 		$609K Buy
247,446
+18,122
+8% +$44.6K ﹤0.01% 3065
2014
Q1 		$608K Buy
229,324
+62,197
+37% +$165K ﹤0.01% 3060
2013
Q4 		$485K Hold
167,127
– – ﹤0.01% 3109
2013
Q3 		$513K Buy
167,127
+6,153
+4% +$18.9K ﹤0.01% 2935
2013
Q2 		$514K Buy
+160,974
New +$514K ﹤0.01% 2857